O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-15.63%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$5.36B
AUM Growth
+$5.36B
(-35%)
Cap. Flow
-$1.44B
Cap. Flow
% of AUM
-26.93%
Top 10 Holdings %
Top 10 Hldgs %
37.64%
Holding
161
New
13
Increased
16
Reduced
46
Closed
30
Top Buys
| 1 |
THOR
Synthorx, Inc. Common Stock
THOR
|
$92.4M |
| 2 |
LOGC
LogicBio Therapeutics, Inc. Common Stock
LOGC
|
$67.3M |
| 3 |
Guardant Health
GH
|
$57.7M |
| 4 |
CVS Health
CVS
|
$52M |
| 5 |
CELG
Celgene Corp
CELG
|
$50.8M |
Top Sells
| 1 |
Jazz Pharmaceuticals
JAZZ
|
$149M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$81.2M |
| 3 |
Edwards Lifesciences
EW
|
$80.4M |
| 4 |
Merck
MRK
|
$80.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
$79M |
Sector Composition
| 1 | Healthcare | 96% |
| 2 | Financials | 0.79% |
